From Europe. For the global patent community.
  • JUVE Patent PaceMaker
  • Advertiser Login
  • Firm Rankings
  • Cases
  • Legal Commentary
  • People & Business
  • Sponsored: Firm Profiles
    • WALLINGER RICKER SCHLOTTER
    • Maiwald Intellectual Property
    • Wildanger PartG mbB
    View all Firm Profiles
    Sponsored: Expert Profiles
    • Heinrich Georg Pannen BDPE Patent- und Rechtsan…
    • Dr. Berthold Lux Maiwald Intellectual Prop…
    • Dr. Jens Pilger, LL.M. DHS
    View all Expert Profiles
    Sponsored Content
    • A whole-of-market-evidence approach t… by BRELA / FRANDLY
    • FRAND Rate-Setting: Convergence on Pr… by BRELA / FRANDLY
    • DeepIP and PatentMaker Join Forces to… by DeepIP
    View all Sponsored Content
Trending Topics:
  • FRAND
  • mRNA vaccines
  • Patent market moves
  • Unified Patent Court
JUVE Patent Healthcare

Healthcare

Cases
Sanofi, Mylan, insulin pen
Biosimilars

Sanofi prevents Mylan marketing insulin pen

Düsseldorf Regional Court has granted French pharmaceutical company Sanofi’s request for a preliminary injunction. It pertains to the dispute with gen ...

5 December 2018 by Konstanze Richter
Cases
UK Supreme Court
Pharma patent

Generics manufacturers gain vital victory at UK Supreme Court

In a landmark decision for the generics industry, the Supreme Court has dismissed Warner-Lambert’s claims of insufficient disclosure, invalidity and i ...

4 December 2018 by Mathieu Klos
People & Business
Long Read

Prescription for the future

The pharmaceutical industry is in upheaval – as are its IP departments. Blockbuster patents are reaching the end of their lives, while new development ...

24 September 2018 by Konstanze Richter
Legal Commentary
©BrowneyseBoyue/AdobeStock
SPC law

At a dead end

Rapid innovation and conflicting interests in the pharmaceutical industry are causing trouble for the outdated EU regulation on the supplementary prot ...

24 September 2018 by Mathieu Klos
arrow-right Created with Sketch.
  • 1
  • …
  • 20
  • 21
  • 22
  • 23
Popular
  • Cases at Paris patent chamber decline for first time in years
  • New FRAND guidelines: Munich Court aims to make proceedings more efficient
  • The mRNA wars are escalating with new claims from Arbutus
© 2026 Juve Patent
 Created with Sketch. LinkedIn
  • Team
  • About us
  • Media Information
  • General Terms and Conditions
  • PaceMaker General Terms & Conditions
  • Privacy Policy
  • Legal Notice
  • Whistleblowing policy
  • Dealing with Artificial Intelligence (AI)
Back to top